Clinical Impact of the Administration of FOLFIRINOX Beyond Six Months in Advanced Pancreatic Adenocarcinoma: A Cohort Study

Background Although a toxic regimen, FOLFIRINOX is one of the most efficient chemotherapy regimens in advanced pancreatic adenocarcinoma. There is no standard number of cycles in locally advanced or metastatic stages. Materials and method The present retrospective study reports the experience of a s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitipir, Cornelia, Vrabie, Radu, Parosanu, Andreea Ioana, Tulin, Raluca, Cretu, Bogdan, Cursaru, Adrian, Slavu, Iulian, Miron, Adrian, Calu, Valentin, Orlov Slavu, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654089/
https://www.ncbi.nlm.nih.gov/pubmed/34925974
http://dx.doi.org/10.7759/cureus.19361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654089/
https://www.ncbi.nlm.nih.gov/pubmed/34925974
http://dx.doi.org/10.7759/cureus.19361

Ejemplares similares